speculating major shareholder has around 500 million shares of Medmira
that were received for in the vicinity of 5 cents each minus bonuses
those 500 million cost them less than $25 million
that's $50 million market cap at .10/sh now
as creditors they'll get the patents first -- at worst --
they are probably looking for 30 to 50 times roi